|
1
|
Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology.
|
Eur Urol
|
2008
|
5.64
|
|
2
|
Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer.
|
Eur Urol
|
2009
|
4.27
|
|
3
|
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.
|
Cancer
|
2008
|
2.53
|
|
4
|
Complications after radical and partial nephrectomy as a function of age.
|
J Urol
|
2010
|
2.36
|
|
5
|
Defining optimal therapy for muscle invasive bladder cancer.
|
J Urol
|
2007
|
2.30
|
|
6
|
Management of low grade papillary bladder tumors.
|
J Urol
|
2007
|
2.04
|
|
7
|
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.
|
J Urol
|
2002
|
1.90
|
|
8
|
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
|
J Urol
|
2007
|
1.87
|
|
9
|
A re-staging transurethral resection predicts early progression of superficial bladder cancer.
|
BJU Int
|
2006
|
1.79
|
|
10
|
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.
|
Eur Urol
|
2007
|
1.76
|
|
11
|
A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.
|
BJU Int
|
2008
|
1.76
|
|
12
|
Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.
|
Cancer
|
2008
|
1.62
|
|
13
|
Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.
|
Urology
|
2007
|
1.56
|
|
14
|
Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
|
J Urol
|
2004
|
1.50
|
|
15
|
Clinical outcomes of primary bladder carcinoma in situ in a contemporary series.
|
J Urol
|
2010
|
1.48
|
|
16
|
Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.
|
J Urol
|
2010
|
1.47
|
|
17
|
Clinical outcome of primary versus secondary bladder carcinoma in situ.
|
J Urol
|
2010
|
1.38
|
|
18
|
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
|
Cancer Immun
|
2003
|
1.19
|
|
19
|
Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.
|
BJU Int
|
2009
|
1.13
|
|
20
|
Quality control in transurethral resection of bladder tumours.
|
BJU Int
|
2008
|
1.08
|
|
21
|
Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence.
|
J Urol
|
2003
|
1.03
|
|
22
|
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
|
Urology
|
2007
|
1.02
|
|
23
|
Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder.
|
J Urol
|
2002
|
1.01
|
|
24
|
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.
|
J Urol
|
2004
|
0.99
|
|
25
|
Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer.
|
BJU Int
|
2006
|
0.98
|
|
26
|
Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer.
|
Cancer
|
2006
|
0.93
|
|
27
|
Natural history of positive urinary cytology after radical cystectomy.
|
J Urol
|
2006
|
0.93
|
|
28
|
Use of urinary biomarkers for bladder cancer surveillance: patient perspectives.
|
J Urol
|
2007
|
0.92
|
|
29
|
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.
|
J Urol
|
2004
|
0.90
|
|
30
|
A plea for a uniform surveillance schedule after radical cystectomy.
|
J Urol
|
2011
|
0.90
|
|
31
|
Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?
|
J Urol
|
2005
|
0.88
|
|
32
|
Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer.
|
BJU Int
|
2013
|
0.88
|
|
33
|
Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome.
|
AJR Am J Roentgenol
|
2008
|
0.87
|
|
34
|
Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.
|
J Urol
|
2007
|
0.85
|
|
35
|
Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology.
|
Urol Oncol
|
2010
|
0.85
|
|
36
|
Preoperative serum albumin is associated with mortality and complications after radical cystectomy.
|
BJU Int
|
2014
|
0.85
|
|
37
|
Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
|
J Urol
|
2006
|
0.84
|
|
38
|
Urinary diversion practice patterns among certifying American urologists.
|
J Urol
|
2012
|
0.84
|
|
39
|
Elisabeth Pauline Pickett (1918-): opening the door for women in urological oncology.
|
J Urol
|
2007
|
0.83
|
|
40
|
Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract.
|
J Urol
|
2006
|
0.83
|
|
41
|
Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.
|
BJU Int
|
2011
|
0.79
|
|
42
|
Urinary diversion: options, patient selection, and outcomes.
|
Semin Oncol
|
2007
|
0.79
|
|
43
|
Perioperative clinical thromboembolic events after radical or partial nephrectomy.
|
Urology
|
2006
|
0.78
|
|
44
|
Early nasogastric tube removal combined with metoclopramide after postchemotherapy retroperitoneal lymph node dissection for metastatic testicular nonseminomatous germ cell tumor.
|
Urology
|
2002
|
0.77
|
|
45
|
Re: Khan et al.: analysis of early complications of robotic-assisted radical cystectomy using a standardized reporting system (Urology 2011;77:357-362).
|
Urology
|
2011
|
0.75
|
|
46
|
Editorial comment.
|
J Urol
|
2010
|
0.75
|
|
47
|
Assessing urological complications of radiation therapy and surgical approaches for repair.
|
J Urol
|
2010
|
0.75
|
|
48
|
Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma.
|
BJU Int
|
2010
|
0.75
|
|
49
|
12th Annual meeting of the Society of Urologic Oncology (SUO) bladder cancer sessions I and II summary report.
|
Urol Oncol
|
2012
|
0.75
|